Agency and strategic contracts: Theory and evidence from R&D agreements in the pharmaceutical industry

Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/19231

Full metadata record

DC Field	Value	Language
dc.contributor.author	Guo, D	-
dc.contributor.author	Hua, X	-
dc.contributor.author	Jiang, K	-
dc.date.accessioned	2019-10-04T11:24:18Z	-
dc.date.available	2017-06-21	-
dc.date.available	2019-10-04T11:24:18Z	-
dc.date.issued	2017-06-21	-
dc.identifier.citation	Guo, D., Hua, X. and Jiang, K. (2017) 'Agency and strategic contracts: Theory and evidence from R&D agreements in the pharmaceutical industry', International Journal of Industrial Organization, 54, pp. 37-64. doi: 10.1016/j.ijindorg.2017.06.007.	en_US
dc.identifier.issn	0167-7187	-
dc.identifier.uri	https://bura.brunel.ac.uk/handle/2438/19231	-
dc.format.extent	37 - 64	-
dc.language.iso	en	en_US
dc.publisher	Elsevier	en_US
dc.subject	agency	en_US
dc.subject	entry threat	en_US
dc.subject	strategic right	en_US
dc.subject	termination	en_US
dc.title	Agency and strategic contracts: Theory and evidence from R&D agreements in the pharmaceutical industry	en_US
dc.type	Article	en_US
dc.identifier.doi	https://doi.org/10.1016/j.ijindorg.2017.06.007	-
dc.relation.isPartOf	International Journal of Industrial Organization	-
pubs.publication-status	Published	-
pubs.volume	54	-
Appears in Collections:	Brunel Business School Research Papers

Files in This Item:

File	Description	Size	Format
FullText.pdf		450 kB	Adobe PDF	View/Open